PTC
BHVN

Philadelphia Trust Company’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Philadelphia Trust Company’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,723
Closed -$916K – 254
2022
Q1 		$916K Sell
7,723
-90
-1% -$10.7K 0.07% 128
2021
Q4 		$1.08M Sell
7,813
-130
-2% -$17.9K 0.08% 121
2021
Q3 		$1.1M Buy
+7,943
New +$1.1M 0.08% 122